| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1378359 | Bioorganic & Medicinal Chemistry Letters | 2005 | 8 Pages |
Several different heterocyclic systems were compared as PDE5 inhibitor scaffolds. In addition to the known 3H-imidazo[5,1-f][1,2,4]triazin-4-ones and pyrazolopyrimidinones, isomeric imidazo[1,5-a][1,3,5]triazin-4(3H)-ones were also shown to be potent and selective PDE inhibitor scaffolds with in vivo activity. SAR trends were elucidated for sulfonamide derivatives with generality across different scaffolds.
Graphical abstractSeveral different heterocyclic systems were compared as PDE5 inhibitor scaffolds. In addition to the known 3H-imidazo[5,1-f][1,2,4]triazin-4-ones and pyrazolopyrimi-dinones, isomeric imidazo[1,5-a][1,3,5]triazin-4(3H)-ones (e.g., 30) were also shown to be potent and selective PDE inhibitor scaffolds with in vivo activity. SAR trends were elucidated for sulfonamide derivatives with generality across different scaffolds.Figure optionsDownload full-size imageDownload as PowerPoint slide
